U.S. health officials investigate new outbreak of parasite cyclospora
The Food and Drug Administration has not yet identified which products are linked to the illnesses.
Drug Administration has recent source-backed changes around An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition and U.S. health officials investigate new outbreak of parasite cyclospora.
3 sources · 3 signals · 4 changes
Latest knowledge change
The U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland. —Valerie Plesch/Bloomberg—Getty Images In a highly unusual move, a U.S. Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, b.
The Food and Drug Administration has not yet identified which products are linked to the illnesses.
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access. (Image credit: Sarah Silbiger).